The first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and ...
Leggi articolo
COSMIC-HF ( Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure ) is a double-blind, randomized, placebo-controlled, ...
Leggi articolo
Data from a new analysis demonstrating that fewer heart failure patients with reduced ejection fraction ( HFrEF ) treated with ...
Leggi articolo
In recent years, a pressing need to develop new, effective and safe drugs against tuberculosis ( TB ) has continued. ...
Leggi articolo
Adjuvant chemotherapy with Vinorelbine plus Cisplatin ( VC ) improves survival in resected non-small-cell lung cancer ( NSCLC ), but ...
Leggi articolo
Evolocumab ( Repatha ) is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 ( PCSK9 ).
...
Leggi articolo
Early diagnosis and treatment of acute promyelocytic leukemia ( APL ), the M3 subtype of acute myeloid leukemia ( AML ...
Leggi articolo
One of the most exciting features of immune checkpoint inhibitors ( ICIs ) is that they provide impressive tumour responses ...
Leggi articolo
Statin intolerance has been a major limitation in the use of statins, especially at higher doses. New effective treatments are ...
Leggi articolo
Dalbavancin ( Xydalba ) is a antibacterial treatment for patients with complicated skin and soft tissue infections ( cSSTI ) ...
Leggi articolo
Sevelamer carbonate ( Renvela ), a buffered form of Sevelamer hydrochloride ( Renagel ), is an orally administered non-absorbed phosphate-binding ...
Leggi articolo
Peginterferon beta-1a ( Plegridy ) is a new therapy that belongs to the same Interferon class as several medications that ...
Leggi articolo
Additional results from AMAGINE-1, a pivotal, multi-arm phase 3 trial evaluating two doses of Brodalumab in patients with moderate-to-severe plaque ...
Leggi articolo
European Commission has granted marketing authorisation for Relvar Ellipta, which is now licensed across 31 European countries for the following ...
Leggi articolo
According to researchers from the University of Toronto and Manchester University an estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis ( ...
Leggi articolo
Merck has announced the presentation of early interim results from a single-arm, open-label phase IB study that has so far ...
Leggi articolo
Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors, such as those ...
Leggi articolo
Idenix Pharmaceuticals has announced that it has received verbal notice from the FDA ( Food and Drug Administration ) that ...
Leggi articolo
Achillion Pharmaceuticals has announced sustained viral response ( SVR4 ) results of 85 to 100% from an ongoing multi-dose Phase ...
Leggi articolo